Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Before-and-after study of linezolid TDM to prevent thrombocytopenia
jRCTs031240652Recruiting
- Sponsor
- University of Tsukuba Hospital Department of Infectious Diseases
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of linezolid in Gram-positive bacterial infection (2 arms), sponsored by University of Tsukuba Hospital Department of Infectious Diseases. Primary endpoint: Time to onset of thrombocytopenia. Started Sep 2025; status: recruiting.
02
Drugs
linezolid
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on jRCTs031240652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240652.